ATRA Earnings

Quarterly EPS
$-2.93
Q3 2024
$-1.18
Q4 2024
$3.53
Q1 2025
$0.20
Q2 2025
$-0.32
Q3 2025
$-0.25
Q4 2025
$-0.29
Q1 2026
$-0.32
Q2 2026
Latest Revenue630.0K
Latest Net Income-4834000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.32630.0K-4834000-96.4%-260.0%
Q1 2026-$0.29516.0K-4145000-99.5%-108.2%
Q4 2025-$0.251.6M-3406000-95.1%+78.8%
Q3 2025-$0.323.5M-4303000-91.4%+89.1%
Q2 2025$0.2017.6M2.4M-38.6%+106.5%
Q1 2025$3.5398.1M38.0M+258.8%+162.5%
Q4 2024-$1.1832.8M-12693000+670.3%+75.7%
Q3 2024-$2.9340.2M-21909000+1,779.8%+82.1%
Q2 2024-$3.1028.6M-19049000
Q1 2024-$5.6527.4M-31752000
Q4 2023-$4.864.3M-60450000
Q3 2023-$16.402.1M-69797000
Atara Biotherapeutics (ATRA) — Earnings